Feeds
5250 items (5250 unread) in 74 feeds
Acinar Cell Carcinoma
(12 unread)
Acinic Cell Carcinoma
(18 unread)
Adenoid Cystic Carcinoma
(90 unread)
Adrenal Gland Cancer
(452 unread)
Ampulla Of Vater
(60 unread)
Anal Cancer
(494 unread)
Angiosarcoma
(130 unread)
Appendix Cancer
(85 unread)
Bile Duct Cancer
(664 unread)
Brain and CNS
(597 unread)
Carcinoid
(153 unread)
Endocrine/Neuroendocrine
(652 unread)
Gall Bladder Cancer
(338 unread)
Hemangioendothelioma
(117 unread)
Hepatoblastoma
(151 unread)
Pancreas
(60 unread)
Phyllodes
(26 unread)
PMP and Mucinous Tumors
(39 unread)
Rhabdomyosarcoma
(187 unread)
Sarcoma
(925 unread)
Google - Adenoid Cystic Carcinoma (62 unread)
-
Lung Neoplasms: Definition, Types, Causes, and Treatment - Verywell Health
Posted: November 30th, 2021, 11:57am GMT
Lung Neoplasms: Definition, Types, Causes, and Treatment Verywell Health -
Lorton Mitchell Memorial Surf Fest | Coronado Island News | coronadonewsca.com - Coronado Eagle and Journal
Posted: November 26th, 2021, 7:13pm GMT
Lorton Mitchell Memorial Surf Fest | Coronado Island News | coronadonewsca.com Coronado Eagle and Journal -
Gasdermin D in colorectal cancer | JIR - Dove Medical Press
Posted: November 24th, 2021, 2:33pm GMT
Gasdermin D in colorectal cancer | JIR Dove Medical Press -
PHOTOS: South Surrey mother's cancer-survival story showcased – Surrey Now-Leader - Surrey Now-Leader
Posted: November 24th, 2021, 11:50am GMT
-
PHOTOS: South Surrey mother's cancer-survival story showcased – Peace Arch News - Peace Arch News
Posted: November 24th, 2021, 11:50am GMT
-
John (Bill) Holsclaw III | Obituaries | wvgazettemail.com - Charleston Gazette-Mail
Posted: November 19th, 2021, 4:00am GMT
John (Bill) Holsclaw III | Obituaries | wvgazettemail.com Charleston Gazette-Mail -
John (Bill) William Holsclaw III | Obituaries | wvgazettemail.com - Charleston Gazette-Mail
Posted: November 19th, 2021, 4:00am GMT
John (Bill) William Holsclaw III | Obituaries | wvgazettemail.com Charleston Gazette-Mail -
IDEAYA BIOSCIENCES, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - marketscreener.com
Posted: November 15th, 2021, 7:07pm GMT
-
IDEAYA Biosciences, Inc. Reports Third Quarter 2021 Financial Results and Provides Business Update - PRNewswire
Posted: November 15th, 2021, 3:45pm GMT
-
'We Don't Know How To Thank You': Rare Cancer Patient Overwhelmed By Financial Support Quarter Of Way To €160000 - Lovin Malta
Posted: November 15th, 2021, 1:11pm GMT
-
Ayala Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update - Yahoo Finance
Posted: November 15th, 2021, 11:00am GMT
-
AYALA PHARMACEUTICALS, INC. Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - marketscreener.com
Posted: November 15th, 2021, 9:36am GMT
-
IDEAYA Biosciences (IDYA) Reports Q3 Results; Issues Business Update - StreetInsider.com
Posted: November 15th, 2021, 9:09am GMT
IDEAYA Biosciences (IDYA) Reports Q3 Results; Issues Business Update StreetInsider.com -
PRELUDE THERAPEUTICS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q) - marketscreener.com
Posted: November 12th, 2021, 11:31am GMT
-
Give Thanks, Get Waves At The Lorton Mitchell Memorial Surf Fest - Coronado Eagle and Journal
Posted: November 12th, 2021, 11:56pm GMT
Give Thanks, Get Waves At The Lorton Mitchell Memorial Surf Fest Coronado Eagle and Journal -
Elevar Therapeutics Receives Orphan Drug Designation from FDA for Rivoceranib for the Treatment of Hepatocellular Carcinoma (HCC) - WFMZ Allentown
Posted: November 11th, 2021, 1:22pm GMT
-
Elevar Therapeutics Receives Orphan Drug Designation from FDA for Rivoceranib for the Treatment of Hepatocellular Carcinoma (HCC) - BioSpace
Posted: November 11th, 2021, 1:22pm GMT
-
Elevar Therapeutics Receives Orphan Drug Designation from FDA for Rivoceranib for the Treatment of Hepatocellular Carcinoma (HCC) - Yahoo Finance
Posted: November 11th, 2021, 1:00pm GMT
-
Elevar Therapeutics Receives Orphan Drug Designation from FDA for Rivoceranib for the Treatment of Hepatocellular Carcinoma (HCC) - KPVI News 6
Posted: November 11th, 2021, 1:00pm GMT
-
Elevar Therapeutics Receives Orphan Drug Designation from FDA for Rivoceranib for the Treatment of Hepatocellular Carcinoma (HCC) - Yahoo Finance
Posted: November 11th, 2021, 1:00pm GMT
-
Elevar Therapeutics Receives Orphan Drug Designation from FDA for Rivoceranib for the Treatment of Hepatocellular Carcinoma (HCC) - PRNewswire
Posted: November 11th, 2021, 1:00pm GMT
-
Rivoceranib Designated Orphan Drug for Hepatocellular Carcinoma - Monthly Prescribing Reference
Posted: November 11th, 2021, 6:00am GMT
Rivoceranib Designated Orphan Drug for Hepatocellular Carcinoma Monthly Prescribing Reference -
MSNBC Has Much to Juggle as Brian Williams, Rachel Maddow Take Next Steps - Yahoo Entertainment
Posted: November 10th, 2021, 9:15pm GMT
MSNBC Has Much to Juggle as Brian Williams, Rachel Maddow Take Next Steps Yahoo Entertainment -
Wendy Williams Is 'Making Progress' amid Health Issues as She Remains Absent from Talk Show - Yahoo Entertainment
Posted: November 10th, 2021, 7:55pm GMT
-
CureVac cites 'promising' data for its investigational cancer injection - MarketWatch
Posted: November 10th, 2021, 11:26am GMT
-
Prognostic factors of OSCC among platelet-related parameters | CMAR - Dove Medical Press
Posted: November 10th, 2021, 7:53am GMT
Prognostic factors of OSCC among platelet-related parameters | CMAR Dove Medical Press -
Ayala Pharmaceuticals to Present at Jefferies London Healthcare Conference - Yahoo Finance
Posted: November 10th, 2021, 6:00am GMT
-
Hundreds brave inclement weather for LOWVELO 2021, raise money for cancer research at Hollings - Medical University of South Carolina
Posted: November 9th, 2021, 2:55pm GMT
Hundreds brave inclement weather for LOWVELO 2021, raise money for cancer research at Hollings Medical University of South Carolina -
Hundreds brave inclement weather for LOWVELO 2021, raise money for cancer research at Hollings - Medical University of South Carolina
Posted: November 9th, 2021, 2:55pm GMT
Hundreds brave inclement weather for LOWVELO 2021, raise money for cancer research at Hollings Medical University of South Carolina -
Shortage of cancer drug abraxane frustrates patients, providers alike - Yahoo News
Posted: November 9th, 2021, 10:48am GMT
-
The Good Life: West Jefferson teen honors father, raises $130,000 for cancer research - The Columbus Dispatch
Posted: November 9th, 2021, 9:24am GMT
The Good Life: West Jefferson teen honors father, raises $130,000 for cancer research The Columbus Dispatch -
2021 Lorton Mitchell Memorial Surf Festival - Coronado Times Newspaper
Posted: November 9th, 2021, 10:55pm GMT
2021 Lorton Mitchell Memorial Surf Festival Coronado Times Newspaper -
Maltese Couple Turns To Public For Help After Being Forced Into €160000 Of Debt To Treat Husband's Rare Cancer - Lovin Malta
Posted: November 8th, 2021, 4:32pm GMT
-
Global Rybrevant Bispecific Antibody Market to 2028 - Featuring Affimed Therapeutics, Amgen and Eli Lilly Among Others - ResearchAndMarkets.com - Maryville Daily Times
Posted: November 5th, 2021, 8:14am GMT
-
Global Rybrevant Bispecific Antibody Market to 2028 - Featuring Affimed Therapeutics, Amgen and Eli Lilly Among Others - ResearchAndMarkets.com - Business Wire
Posted: November 5th, 2021, 8:14am GMT
-
Preventing Leukemia By Preventing Rogue Blood Cells From Taking Over - Todayuknews - Todayuknews
Posted: November 5th, 2021, 2:24am GMT
-
Ayala (AYLA) gains 1.18% for November 4 - Equities.com
Posted: November 5th, 2021, 11:37pm GMT
Ayala (AYLA) gains 1.18% for November 4 Equities.com -
Curbing clonal hematopoiesis to prevent leukemia - Boston Children's Answers - Boston Children's Discoveries
Posted: November 4th, 2021, 4:05pm GMT
Curbing clonal hematopoiesis to prevent leukemia - Boston Children's Answers Boston Children's Discoveries -
Ayala (AYLA) gains 3.59% on Moderate Volume November 3 - Equities.com
Posted: November 4th, 2021, 11:10pm GMT
-
Ayala (AYLA) falls 2.48% to Close at $10.60 on November 2 - Equities.com
Posted: November 3rd, 2021, 11:40pm GMT
-
Cancer survivor finds community and support while staying physically active - Medical University of South Carolina
Posted: November 2nd, 2021, 6:17pm GMT
Cancer survivor finds community and support while staying physically active Medical University of South Carolina -
Salivary Gland Cancer Treatment Market Impact of Existing and Emerging Flexible Trends and Top Key Players (GE, Siemens, Accuray, Elekta) | Forecasts 2021-2028 – Chip Design Magazine - Chip Design Magazine
Posted: November 1st, 2021, 6:02pm GMT
-
Gregory Newton | Obituary | Commercial News - Danville Commercial News
Posted: November 1st, 2021, 4:02pm GMT
Gregory Newton | Obituary | Commercial News Danville Commercial News -
Deborah Lynn Bryant Ellis, 57, Registered Nurse - WYDaily
Posted: October 30th, 2021, 11:13am GMT
-
Ayala (AYLA) gains 4.08% to Close at $10.98 on October 29 - Equities.com
Posted: October 30th, 2021, 11:37pm GMT
-
Ayala (AYLA) gains 8.09% in Light Trading on October 28 - Equities.com
Posted: October 29th, 2021, 11:37pm GMT
-
Genetic Testing in CYLD Cutaneous Syndrome: An Update | TACG - Dove Medical Press
Posted: October 28th, 2021, 2:21pm GMT
Genetic Testing in CYLD Cutaneous Syndrome: An Update | TACG Dove Medical Press -
Staying Afloat By Sharing Stories - Bay Weekly - Bay Weekly
Posted: October 28th, 2021, 12:01pm GMT
-
Courage like Courtney: Perham cross country runner focuses on the best in life in her battle with skin cancer - Perham Focus
Posted: October 27th, 2021, 9:04pm GMT
-
Salivary Gland Cancer Treatment Market 2021: Upcoming Trends, Demand, Regional Analysis and Top Key Vendors (GE, Siemens, Accuray, Elekta) | Forecast To 2028 – The Manomet Current - The Manomet Current
Posted: October 26th, 2021, 4:59pm GMT
-
Ayala (AYLA) falls 0.10% on Strong Volume October 25 - Equities.com
Posted: October 26th, 2021, 11:40pm GMT
Ayala (AYLA) falls 0.10% on Strong Volume October 25 Equities.com -
Why Did Prelude Therapeutics Stock Tumble To 52-Week Low Today? - Yahoo Finance
Posted: October 7th, 2021, 5:00am GMT
-
Adenoid Cystic Carcinoma: Overview and More - Verywell Health
Posted: September 22nd, 2021, 5:00am GMT
Adenoid Cystic Carcinoma: Overview and More Verywell Health -
Ayala Pharmaceuticals Presents Preliminary Clinical Data - GlobeNewswire
Posted: September 16th, 2021, 5:00am GMT
Ayala Pharmaceuticals Presents Preliminary Clinical Data GlobeNewswire -
Osteosarcoma: Signs and Complications - Verywell Health
Posted: September 13th, 2021, 5:00am GMT
Osteosarcoma: Signs and Complications Verywell Health -
Symptoms of Salivary Gland Cancer - Verywell Health
Posted: August 23rd, 2021, 5:00am GMT
Symptoms of Salivary Gland Cancer Verywell Health -
Ayala Pharmaceuticals Reports Third Quarter 2020 Financial - GlobeNewswire
Posted: November 17th, 2020, 6:00am GMT
-
You’ve to believe you can fight it: Cancer survivor Arun Lal on COVID-19 - Hindustan Times
Posted: April 20th, 2020, 5:00am GMT
-
Mucoepidermoid Carcinoma Causing Localized Recurrent Pneumonia in a 7-Year-Old Boy - Consultant360
Posted: February 6th, 2020, 6:00am GMT
-
‘Brave Like Gabe’: Remembering the Runner Who Never Gave Up in the Face of an Unbeatable Opponent - Sports Illustrated
Posted: June 11th, 2019, 5:00am GMT
-
V Foundation Announces Translational Grant Awarded in Partnership with Adenoid Cystic Carcinoma Research Foundation - Curetoday.com
Posted: May 21st, 2019, 5:00am GMT
-
Overexpression of PD-L2 is associated with shorter relapse-free surviv | OTT - Dove Medical Press
Posted: June 13th, 2017, 5:00am GMT
Overexpression of PD-L2 is associated with shorter relapse-free surviv | OTT Dove Medical Press